Malaysia’s Leading Stem Cell Bank

Established in 2002, CryoCord has become one of Malaysia’s most comprehensive private stem cell banks, specialising in the long-term cryopreservation of human stem cells and tissues. Licensed under the Private Healthcare Facilities and Services Act 1998, CryoCord combines rigorous scientific standards and advanced technology to offer families reliable solutions for their children’s health.

The laboratory is accredited by AABB and ISO 15189 and certified to Current Good Manufacturing Practice (cGMP) under PIC/S standards. This ensures every sample is handled, processed, and stored according to the highest international protocols. Thousands of families have entrusted CryoCord to safeguard their baby’s cord blood and tissue stem cells, turning what was once considered medical waste into a valuable resource for future therapies.

CryoCord is committed not only to storage but also to raising awareness of stem cell science. Parent consultations help families understand potential applications and long-term benefits, empowering them to make informed decisions about their children’s health.

Advanced Technology for Long-Term Preservation

CryoCord uses state-of-the-art cryogenic systems to preserve stem cells over decades. Automated monitoring ensures every sample remains secure, while research-backed methods maximise cell longevity.

Preparedness is key to delivering life-saving solutions. As Malaysia’s only cGMP-certified stem cell bank, CryoCord strengthens emergency readiness by expanding stem cells before storage. This proactive approach ensures a robust inventory, allowing healthcare professionals to respond swiftly to urgent medical needs and eliminating delays in critical treatments.

Mesenchymal stem cells (MSCs), the body’s raw materials, can develop into specialised cells that aid tissue repair and organ regeneration. CryoCord’s pre-storage expansion enhances treatment availability for patients with graft-versus-host disease, stroke, spinal cord injuries, and degenerative diseases.

CryoCord Group has obtained three US patents and twelve Malaysia patents for cell-based technologies, including a patent for MSC culture media, which is crucial in determining cell quality. The laboratory also houses 10 Grade B (ISO Class 5) cleanrooms and the largest Biosafety Level 2 (BSL-2) GMP facility in Southeast Asia. From umbilical cord-derived stem cells to tooth and bone marrow sources, each sample is carefully tracked, handled, and preserved to guarantee precision, safety, and long-term viability.

Expertise Backed by Science

CryoCord is led by academic and medical experts, including Emeritus Professor Dr. Cheong Soon Keng, whose vision emphasises both scientific rigor and innovation. The team participates in national and international conferences to stay at the forefront of regenerative medicine and stem cell research. Continuous professional development ensures staff are equipped to handle samples and guide families on potential therapies.

The centre also collaborates with researchers and medical institutions to advance studies in regenerative medicine. CryoCord actively contributes to medical breakthroughs that could redefine the treatment of complex diseases. Its clinical trials for MSCs are approved by the Ministry of Health Malaysia, further cementing its credibility in pioneering new treatments.

Safety, Compliance, and Quality Assurance

Safety is central to CryoCord’s operations. Standard operating procedures are strictly followed at every stage of collection, processing, and storage. Regular internal and external audits ensure compliance with regulatory standards, while contingency plans protect samples during transport or storage emergencies.

The laboratory’s cGMP certification and ISO accreditations reinforce credibility and reliability. Parents can trust that CryoCord’s operations meet the highest international standards, providing secure and dependable stem cell storage for decades. Detailed reports and transparent communication allow families to track collection, processing, and storage, reinforcing accountability and trust.

Investing in the Future of Health

Stem cell storage is not only a protective measure for today but also an investment in tomorrow’s medical possibilities. CryoCord enables parents to prepare for therapies that may not yet exist, offering access to treatments for diseases currently considered incurable. By investing in pre-expanded MSCs, CryoCord enhances treatment readiness, ensuring that life-saving interventions can be delivered without delay.

Families who choose CryoCord gain more than storage, they gain peace of mind. Advanced technology, expert handling, patent-backed innovations, and a commitment to research ensure every stored sample is ready to meet the medical challenges of tomorrow. Flexible collection options and long-term storage plans make stem cell preservation accessible and manageable for families.

Leadership in Innovation

CryoCord’s dedication to science, technology, and quality has positioned it as a pioneer in the region. By combining world-class facilities, pre-expanded MSC reserves, and a forward-looking approach to medicine, CryoCord leads stem cell banking in Southeast Asia. Its focus on rigorous standards, research, and innovation ensures families invest not only in storage but in a future where medical breakthroughs are within reach.

By staying at the forefront of scientific innovation, including patents, MSC expansion, and emergency readiness strategies, CryoCord transforms stem cell banking from a medical service into a strategic, long-term health investment for families. Parents can make proactive, evidence-backed decisions, securing the health potential of their children and embracing a future-ready approach to lifelong wellness.